Skip to main content

Cell Sorting Market

The global cell sorting market is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market.
Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, followed by Europe and Asia-Pacific. Emerging markets, including India and China, have become attractive destinations for companies engaged in the development and marketing of cell sorters. Rising incidence and prevalence of cancer, HIV, leukemia, thalassemia, and Alzheimer’s disease is among the major driving factors for the growth of this market in China and India. For instance, according to the World Cancer Report 2014, China is witnessing an alarming rise in cancer incidences-it saw an estimated 3.07 million new cancer cases in 2012, accounting for 21.8% of the global new cancer cases. As many as 2.2 million cancer deaths (26.9% of global cancer deaths) were reported in this country in the same year. In addition to this, increasing research initiatives, expansions by key players, and technological advancements are the key factors propelling the demand for cell sorters in the emerging markets.
As of 2015, Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.) dominated the global cell sorting market. In the past three years, these companies adopted product launches, product showcase, agreements, and partnerships as their key business strategies to ensure market dominance. Miltenyi Biotec GmbH (Germany), Sony Biotechnology, Inc. (U.S.), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.) are some of the other players in this market.
Labels:

Comments

Post a Comment

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type
Post a Comment
Read more

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i
Post a Comment
Read more

Dental Bone Graft Substitutes Market Size, Share, Growth Drivers, Industry Analysis

The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Increasing demand from customers for dental bone graft substitutes, growing inclination towards cosmetic dentistry, and rising industry standards are spurring the growth of the dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of the dental bone grafts substitutes market. The global dental bone graft substitutes market is segmented on the basis of type, application, and region. The geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). RoW includes Latin America, the Middle East, and Africa. The European region is estimated to account for the largest share of the dental bone graft substitutes market in 2016. As implant dentistry originated in the European region, the penetration rate of dental bone graft substitutes is very high in
Post a Comment
Read more